Mount Sinai is at the epicenter of high-impact translational brain research. We are proud to host and support a number of programs that have been transformational in nature and scope. These programs are listed below.
Vahram Haroutunian, PhD, Director
The NeuroBioBank (NBB) is an NIH-funded program established in 2013 with specimens that span neurological, neuropsychiatric and neurodevelopmental diseases and disorders. This network consists of six biorepositories, including Mount Sinai.
The Mount Sinai NIH-funded Alzheimer’s Disease Research Center’s (ADRC) Neuropathology Core obtains autopsy-derived brain specimens from individuals who have been evaluated and followed longitudinally. These specimens have a detailed neuropathologic work-up to establish a neuropathologic diagnosis as well as to document the extent and distribution of relevant neuropathologic lesions and enter all data into an extensive database that can be integrated into the clinical database for cliniconeuropathologic correlative investigations. The tissues collected have been used extensively in a wide range of studies. These specimens are available to investigators within the ADRC, in the greater Mount Sinai research community, and by other researchers nationally and internationally.
The Manhattan HIV Brain Bank’s mission is to help all of those infected with HIV by supporting diverse translational research projects focused on AIDS pathogenesis. This core collects a variety of samples for research on, but not limited to, brain, spinal cord, liver, spleen, kidney, heart, lung, lymph node, genitourinary tract, muscle, and peripheral nerves. Tissues are available both in fixed and frozen formats. Tissues, fluids, and de-identified clinical data are available free of charge to qualified researchers.
Autism BrainNet is a network of University-based repositories for the acquisition and distribution of postmortem brain and other tissue to facilitate autism research. Autism BrainNet aims to improve the understanding, diagnosis and treatment of autism and related neurodevelopmental disorders. Investigators may submit an application that will undergo peer review by the Scientific Review Committee. Those applications that meet our criteria will be forwarded to the Steering Committee and discussed at our review meetings for final recommendation. While there is no cost for tissue specimens, investigators will be responsible for the cost of shipping.